Chimeric antigen receptor T cells - Globe Thesis

Keyword [Chimeric antigen receptor T cells] Result: 21 - 40 \| Page: 2 of 4
21.	The Study Of Chimeric Antigen Receptor T Cells Targeting Mesothelin For The Treatment Of Pancreatic Adenocarcinoma
22.	Basic And Clinical Study On CD19-CAR-T Cells For B Cell Non-hodgkin Lymphoma
23.	Establishment Of A Quantitative PCR Assay For Monitoring Chimeric Antigen Receptor T Cells In Peripheral Blood
24.	Sulforaphane Enhance The Anti-Tumor Efficiency Of Chimeric Antigen Receptor T Cells
25.	Efficacy And Safety Of CD19 CAR-T Cells In Refractory/Recurrent Acute B-Lymphoblastic Leukemia:A Meta-analysis
26.	In Vitro Study Of Chimeric Antigen Receptor Modified T Cells Targeting IL-13Rα2 Against Glioblastoma
27.	Correlative Study On The Efficacy And Complications Of CD19 Chimeric Antigen Receptor T Cells In The Treatment Of Recurrent/Refractory Acute Lymphoblastic Leukemia
28.	Study On The Killing Effect Of H3 Chimeric Antigen Receptor T Cells On MDA-MB-231 Cells
29.	T-cell Receptor-like Nanobody Chimeric Antigen Receptor T-cells Directed Towards Tumor Antigen
30.	Antitumor Activity Of Anti-EGFR Chimeric Antigen Receptor T Cells Against Glioblastoma In Vitro And In Vivo
31.	Construction And Functional Study Of Chimeric Antigen Receptor T Cells With IL-12R Intracellular Domain
32.	Construction And Effects Of CD26 Chimeric Antigen Receptor T Cells Targeting CML Stem Cells
33.	Comparison Of Anti-tumor Ability Of CAR-T Cells Based On Affinity Of ScFv
34.	Studies On The Effects Of Anti-CD 19 Chimeric Antigen Receptor T Cells In Vitro And The Molecular Mechanisms
35.	Studies On The Abilities And Safety Of Anti-CD19 Chimeric Antigen Receptor T Cells In Killing Lymphomain Vivo
36.	Clinical Study Of Chimeric Antigen Receptor T Cell In Relapsed/Refractory B Cell Non-Hodgkin’s Lymphoma
37.	A Preliminary Study On The Safety And Efficacy Of CD19-targeted Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed/refractory Philadelphia Chromosome Positive Acute B Lymphocytic Leukemia
38.	Safety And Efficacy Of CAR-T In The Treatment Of Relapsed Or Refractory B-cell Hematologic Malignant Tumors: An Open-label,uncontrolled,single-center Clinical Study
39.	The Efficacy And Safety Of Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed/refractory B-cell Acute Lymphoblastic Leukemia
40.	Study On Chimeric Antigen Receptor T Cells Targeting CML Leukemia Stem Cells
<<First <Prev Next> Last>> Jump to